NCT06983119

Brief Summary

Dementia is a global public health challenge with a heavy caregiving burden, impacting families, communities, and healthcare systems. It is a priority in healthcare planning, with focus on early diagnosis and ongoing support. This research project addresses the global public health challenge posed by dementia, focusing on early detection and comprehensive care. The research evaluates the clinical, social, and healthcare impact of two dementia-related projects in Italy:

  1. 1.the first "Ricor-Dare," aims to create an integrated network for identifying new cases of dementia or Mild Cognitive Impairment (MCI) and providing care to patients and caregivers;
  2. 2.the second involves establishing a new Center for Cognitive Disorders and Dementia (CCDD) in an area previously lacking such services.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
490

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jul 2024Jul 2026

Study Start

First participant enrolled

July 11, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

April 14, 2025

Last Update Submit

May 13, 2025

Conditions

Keywords

Case-findingDementiaMild Cognitive ImpairmentMemory ClinicCenter for Cognitive Disorders and DementiaNon-pharmacological interventionCaregiverBurden

Outcome Measures

Primary Outcomes (1)

  • Effects of the case-finding strategy for the early detection of dementia in its prodromal or initial stages.

    The number of individuals, from the three case-finding settings, diagnosed at the CCDD with Mild Cognitive Impairment (MCI) or dementia within 26 months following assessment at case-finding compared to the total number of people identified as positive cases through GPcog and/or ACE-III and assessed within the three different case-finding settings.

    Up to 26 months

Secondary Outcomes (6)

  • The impact of the new CCDD on clinical care in an area that previously lacked such services.

    Up to 26 months

  • Patient and caregiver satisfaction with accessing the new CCDD.

    Up to 26 months

  • The impact of the diagnostic-care pathway for caregivers at CCDD and "Ricor-Dare" project.

    Up to 26 months

  • The impact of the "Dementia Operations Center (COD)" pathway of the "Ricor-Dare" project.

    Up to 26 months

  • The impact of education activities on dementia promoted by the "Ricor-Dare" project.

    Up to 26 months

  • +1 more secondary outcomes

Study Arms (1)

Detection of people reporting cognitive concerns

OTHER
Other: Case-finding for Neurocognitive Disorders

Interventions

The intervention targets individuals reporting cognitive concerns without a prior diagnosis of MCI or dementia, with participants accessing three different settings for evaluation. The first setting involves General Practitioner (GP) offices, where GPs, trained in dementia risk factors and cognitive assessment tools (such as GPcog), will identify at-risk patients and refer them for further evaluation at a Center for Cognitive Disorders and Dementia (CCDD). The second setting is the Dementia Operations Center (COD) Information Desk, a public service where neuropsychologists assess citizens who independently report cognitive disturbances. The third setting includes Open Days, public events aimed at detecting early signs of cognitive decline, where neuropsychologists will assess participants using the Addenbrooke's Cognitive Examination-III (ACE-III) and the LIBRA Index. Individuals identified as at-risk in any of the three settings will be referred for further evaluation at a CCDD.

Detection of people reporting cognitive concerns

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 50 or older
  • Assessment conducted using GPcog/ACE-III depending on the setting
  • No prior diagnosis of cognitive decline
  • Ability to understand the study objectives and sign an informed consent

You may not qualify if:

  • Age under 50
  • Presence of a diagnosis of cognitive decline
  • Limited knowledge of the Italian language
  • Patient:
  • All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina;
  • Ability to understand the aims of the study and to sign an informed consent
  • Caregiver:
  • Age equal to or greater than 18 years
  • Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the clinical-care pathway of the CDCD;
  • Acceptance of informed consent and voluntary participation in the study.
  • Healthcare professionals:
  • All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and training;
  • Acceptance of informed consent and voluntary participation in the study.
  • Patient:
  • \- Inability to understand the aims of the study and to sign an informed consent
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS National Neurological Institute "C. Mondino" Foundation

Pavia, Pavia, 27100, Italy

RECRUITING

Related Publications (11)

  • Shanahan N, Orrell M, Schepers AK, Spector A. The development and evaluation of the DK-20: a knowledge of dementia measure. Int Psychogeriatr. 2013 Nov;25(11):1899-907. doi: 10.1017/S1041610213001142. Epub 2013 Aug 15.

    PMID: 23947900BACKGROUND
  • Pucciarelli G, Savini S, Byun E, Simeone S, Barbaranelli C, Vela RJ, Alvaro R, Vellone E. Psychometric properties of the Caregiver Preparedness Scale in caregivers of stroke survivors. Heart Lung. 2014 Nov-Dec;43(6):555-60. doi: 10.1016/j.hrtlng.2014.08.004. Epub 2014 Sep 18.

    PMID: 25239706BACKGROUND
  • Chattat R, Cortesi V, Izzicupo F, Del Re ML, Sgarbi C, Fabbo A, Bergonzini E. The Italian version of the Zarit Burden interview: a validation study. Int Psychogeriatr. 2011 Jun;23(5):797-805. doi: 10.1017/S1041610210002218. Epub 2010 Dec 16.

    PMID: 21205379BACKGROUND
  • Pigliautile M, Chiesi F, Stablum F, Rossetti S, Primi C, Chiloiro D, Federici S, Mecocci P. Italian version and normative data of Addenbrooke's Cognitive Examination III. Int Psychogeriatr. 2019 Feb;31(2):241-249. doi: 10.1017/S104161021800073X. Epub 2018 Jul 19.

    PMID: 30021668BACKGROUND
  • Franchini F, Musicco M, Ratto F, Storti G, Shofany J, Caltagirone C, Di Santo SG. The LIBRA Index in Relation to Cognitive Function, Functional Independence, and Psycho-Behavioral Symptoms in a Sample of Non-Institutionalized Seniors at Risk of Dementia. J Alzheimers Dis. 2019;72(3):717-731. doi: 10.3233/JAD-190495.

    PMID: 31640092BACKGROUND
  • Pirani A, Brodaty H, Martini E, Zaccherini D, Neviani F, Neri M. The validation of the Italian version of the GPCOG (GPCOG-It): a contribution to cross-national implementation of a screening test for dementia in general practice. Int Psychogeriatr. 2010 Feb;22(1):82-90. doi: 10.1017/S104161020999113X. Epub 2009 Nov 6.

    PMID: 19891815BACKGROUND
  • Banerjee S, Wittenberg R. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriatr Psychiatry. 2009 Jul;24(7):748-54. doi: 10.1002/gps.2191.

    PMID: 19206079BACKGROUND
  • Steiner GZ, Ee C, Dubois S, MacMillan F, George ES, McBride KA, Karamacoska D, McDonald K, Harley A, Abramov G, Andrews-Marney ER, Cave AE, Hohenberg MI. "We need a one-stop-shop": co-creating the model of care for a multidisciplinary memory clinic with community members, GPs, aged care workers, service providers, and policy-makers. BMC Geriatr. 2020 Feb 11;20(1):49. doi: 10.1186/s12877-019-1410-x.

    PMID: 32046657BACKGROUND
  • Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013 Jan;9(1):63-75.e2. doi: 10.1016/j.jalz.2012.11.007.

    PMID: 23305823BACKGROUND
  • Sachdev PS, Lipnicki DM, Kochan NA, Crawford JD, Thalamuthu A, Andrews G, Brayne C, Matthews FE, Stephan BC, Lipton RB, Katz MJ, Ritchie K, Carriere I, Ancelin ML, Lam LC, Wong CH, Fung AW, Guaita A, Vaccaro R, Davin A, Ganguli M, Dodge H, Hughes T, Anstey KJ, Cherbuin N, Butterworth P, Ng TP, Gao Q, Reppermund S, Brodaty H, Schupf N, Manly J, Stern Y, Lobo A, Lopez-Anton R, Santabarbara J; Cohort Studies of Memory in an International Consortium (COSMIC). The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. PLoS One. 2015 Nov 5;10(11):e0142388. doi: 10.1371/journal.pone.0142388. eCollection 2015.

    PMID: 26539987BACKGROUND
  • Bacigalupo I, Mayer F, Lacorte E, Di Pucchio A, Marzolini F, Canevelli M, Di Fiandra T, Vanacore N. A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria. J Alzheimers Dis. 2018;66(4):1471-1481. doi: 10.3233/JAD-180416.

    PMID: 30412486BACKGROUND

Related Links

MeSH Terms

Conditions

DementiaCognitive Dysfunction

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Study Officials

  • Alfredo Costa, MD

    IRCCS National Neurological Institute "C. Mondino" Foundation

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2025

First Posted

May 21, 2025

Study Start

July 11, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations